Risk of Subsequent Breast Cancer in Women with Early Stage HER2-Positive Breast Cancer in a Large Community Health Plan by Haque R, Chen LH, Oestreicher N, Lalla D, Chlebowski RT

Get full text

Effect of central nervous system metastases on treatment discontinuation and survival in older women receiving trastuzumab for metastatic breast cancer. by Danese, MD, Lindquist, K, Doan, J, Lalla, D, Brammer, M, Griffiths, R

Infused therapy and survival in older patients diagnosed with metastatic breast cancer who received trastuzumab. by Griffiths, R, Lalla, D, Herbert, R, Doan, J, Brammer, MG, Danese, MD